Showing results (331-340 of 536) with videos related to

Sort By:
Pageof 54
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysisElda Righi, Anna Maria Peri, Patrick N A Harris, et al.
Metabolites|October 22, 2021
Abiotic and Biotic Damage of Microalgae Generate Different Volatile Organic Compounds (VOCs) for Early Diagnosis of Algal Cultures for Biofuel ProductionKristen L Reese, Carolyn L Fisher, Pamela D Lane, et al.
Cancer|April 1, 1977
The changing histopathology of lung cancer: a review of 1682 casesR G Vincent, J W Pickren, W W Lane, et al.
The American Journal of Cardiology|October 6, 2010
Depressive symptoms and all-cause mortality in unstable angina pectoris (from the Coronary Psychosocial Evaluation Studies [COPES])William Whang, Daichi Shimbo, Ian M Kronish, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1991
Hairpatches, a single gene mutation characterized by progressive renal disease and alopecia in the mouse. A potential model for a newly described heritable human disorderL D Shultz, P W Lane, D R Coman, et al.
Biotechniques|March 6, 2003
Multifactorial screening design and analysis of SELDI-TOF ProteinChip array optimization experimentsH C Cordingley, S L L Roberts, P Tooke, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 30, 2011
Reduced isotope dose and imaging time with a high-efficiency CZT SPECT cameraW Lane Duvall, Lori B Croft, Eric S Ginsberg, et al.
STAR Protocols|July 1, 2026
LOTR-Seq: A protocol for large-scale simultaneous single-cell long-read genotyping of transcriptsJulian Grabek, Leanne Cooper, Rohit Haldar, et al.
Connecticut Medicine|October 16, 2014
A simple scoring tool for the evaluation of patients in an emergency department chest pain unitW Lane Duvall, Elliot Levine, Usman Baber, et al.
Plos One|June 18, 2015
EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or LeukemiaSara Charmsaz, Kirrilee Beckett, Fiona M Smith, et al.
Pageof 54